TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
KADIN wants greater collaboration for medical devices business with Japan
As part of the effort, KADIN last week dispatched a 15-member delegation, comprising representatives from nine of Indonesia's pharmaceutical and medical-device manufacturers to meet their Japanese counterparts.
Change Size
Chairman of Japan Committee of the Indonesian Chamber of Commerce (KADIN) Wandi Wanandi, Secretary General of the Association of Medical Equipment Manufacturers (Aspaki) Christina Sandjaja, David Utama of the Indonesian Association of Pharmaceutical Companies (GP Farmasi) and Vice President of the Japanese pharmaceutical firm Takeda Atsushi Seki speak during a seminar organized by the Indonesian Embassy in Tokyo. (The Jakarta Post/KADIN)
The Indonesian Chamber of Commerce (KADIN) is pushing for a greater collaboration between Indonesia and Japan in the business of pharmaceutical and medical devices as part of the country's effort to boost global health cooperation under the Group of Twenty (G20).
As part of the effort, KADIN last week dispatched a 15-member delegation, comprising representatives from nine of Indonesia's pharmaceutical and medical-device manufacturers to meet their Japanese counterparts in an event organized by the Indonesian Embassy in Tokyo and the Indonesian Consulate General in Osaka.
One of the outcomes from the series of meetings with Japanese business groups was the signing of a commitment between the Indonesian Association of Pharmaceutical Companies (GPFI) and the Association of Medical Equipments Manufactures (ASPAKI) with the Federation of Pharmaceutical Manufacturers Association of Japan (FPMAJ).
"FPMAJ is honored to be part of this, and we look forward to furthering our collaboration with Indonesia in medical fields," FPMAJ general director Toshihiko Miyajima said.
Drugs and Food Monitoring Agency (BPOM) head Penny Lukito said that the Indonesian government fully backed the collaboration.
"The Indonesian market is a significant factor that could draw in Japanese investors. So I invite Japanese pharmaceutical business players to further collaborate with Indonesia through research and technology-based medicine development," Penny said in her speech.
Indonesia's pharmaceutical and medical devices business is worth US$10.1 billion in 2021 and is expected to grow in the coming year with the expanding middle class.
The Indonesian Embassy in Tokyo has said that the collaboration between Indonesia and Japan could further be enhanced especially in the context of G20.
"The event today is the realization of one of pillars of G20 in global health collaboration," Indonesian Ambassador to Japan Heri Akhmadi said.
